CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+16.29%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$7.82B
AUM Growth
+$7.82B
(+20%)
Cap. Flow
+$215M
Cap. Flow
% of AUM
2.74%
Top 10 Holdings %
Top 10 Hldgs %
19.27%
Holding
875
New
65
Increased
352
Reduced
239
Closed
80
Top Buys
| 1 |
Merck
MRK
|
$46.7M |
| 2 |
Bristol-Myers Squibb
BMY
|
$29.1M |
| 3 |
Gilead Sciences
GILD
|
$27.9M |
| 4 |
BZUN
Baozun
BZUN
|
$26.6M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$26.5M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$81.1M |
| 2 |
Danaher
DHR
|
$31.9M |
| 3 |
LOXO
Loxo Oncology, Inc
LOXO
|
$28.1M |
| 4 |
Agilent Technologies
A
|
$28M |
| 5 |
McCormick & Company Non-Voting
MKC
|
$20.1M |
Sector Composition
| 1 | Healthcare | 33.36% |
| 2 | Technology | 16% |
| 3 | Financials | 11.25% |
| 4 | Consumer Discretionary | 8.98% |
| 5 | Communication Services | 7.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
PTC Therapeutics
PTCT
$4.41B
| $17.4M | 0.22% |
462,523
+60,000
| +15% | +$2.26M |
|
102
Fortive
FTV
$15.9B
| $17.1M | 0.22% |
203,688
+171,401
| +531% | +$14.4M |
|
103
PACCAR
PCAR
$50.5B
| $17.1M | 0.22% |
250,755
-28,083
| -10% | -$1.91M |
|
104
Exelixis
EXEL
$9.95B
| $17M | 0.22% |
713,142
+165,182
| +30% | +$3.93M |
|
105
Pfizer
PFE
$141B
| $16.9M | 0.22% |
398,975
-55,073
| -12% | -$2.34M |
|
|
NOAH
106
Noah Holdings
NOAH
$812M
| $16.6M | 0.21% |
+343,000
| New | +$16.6M |
|
107
EOG Resources
EOG
$65.8B
| $16.5M | 0.21% |
173,449
+121,317
| +233% | +$11.5M |
|
108
Varonis Systems
VRNS
$6.21B
| $16.3M | 0.21% |
273,752
+95,378
| +53% | +$5.69M |
|
|
DFS
109
DELISTED
Discover Financial Services
DFS
| $16.2M | 0.21% |
228,079
-13,760
| -6% | -$979K |
|
110
Bank of America
BAC
$371B
| $16.2M | 0.21% |
586,297
-41,807
| -7% | -$1.15M |
|
111
Estee Lauder
EL
$33.1B
| $16.1M | 0.21% |
97,347
-88,676
| -48% | -$14.7M |
|
|
USG
112
DELISTED
Usg
USG
| $16.1M | 0.21% |
371,000
+271,000
| +271% | +$11.7M |
|
113
Delta Air Lines
DAL
$40B
| $16M | 0.2% |
309,644
+280,102
| +948% | +$14.5M |
|
114
FibroGen
FGEN
$48.4M
| $15.8M | 0.2% |
290,900
-60,000
| -17% | -$3.26M |
|
|
HOLI
115
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $15.5M | 0.2% |
742,244
+290,645
| +64% | +$6.09M |
|
116
Netflix
NFLX
$521B
| $15.5M | 0.2% |
43,364
+1,702
| +4% | +$607K |
|
117
Cigna
CI
$80.2B
| $15M | 0.19% |
93,017
-26,704
| -22% | -$4.29M |
|
118
Silicon Laboratories
SLAB
$4.3B
| $14.9M | 0.19% |
184,118
+71,471
| +63% | +$5.78M |
|
119
Labcorp
LH
$22.8B
| $14.8M | 0.19% |
96,953
+73,004
| +305% | +$11.2M |
|
120
Colgate-Palmolive
CL
$67.7B
| $14.6M | 0.19% |
200,326
-59,168
| -23% | -$4.32M |
|
121
ConocoPhillips
COP
$118B
| $14.6M | 0.19% |
218,480
-34,008
| -13% | -$2.27M |
|
122
Mondelez International
MDLZ
$79.3B
| $14.5M | 0.19% |
242,427
+79,319
| +49% | +$4.76M |
|
123
Nektar Therapeutics
NKTR
$543M
| $14.4M | 0.18% |
428,791
-17,415
| -4% | -$585K |
|
124
Heron Therapeutics
HRTX
$204M
| $14.4M | 0.18% |
588,600
+125,000
| +27% | +$3.06M |
|
125
Franklin Resources
BEN
$13.3B
| $14.4M | 0.18% |
433,621
-54,635
| -11% | -$1.81M |
|